Low free and bioavailable testosterone levels may predict pathologicallyproven high-risk prostate cancer: a prospective, clinical trial

---

Bayar G., Şirin H., Aydın M., Özağarı A., TANRIVERDİ O., KADIHASANOĞLU M., ...Daha Fazla

TURKISH JOURNAL OF UROLOGY, cilt.43, sa.3, ss.289-296, 2017 (ESCI, Scopus, TRDizin)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 43 Sayı: 3
• Basım Tarihi: 2017
• Doi Numarası: 10.5152/tud.2017.35467
• Dergi Adı: TURKISH JOURNAL OF UROLOGY
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.289-296
• Anahtar Kelimeler: Prostate cancer, prostate-specific antigen, radical prostatectomy, testosterone, transrectal prostate biopsy, LOW SERUM TESTOSTERONE, REPLACEMENT THERAPY, STAGE, MEN, HYPOGONADISM, PROGNOSIS, DISEASE
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objective: To determine the predictive value of free and bioavailable testosterone levels on the detection of high-grade prostate cancer proven by histopathological examination of transrectal prostate biopsy specimens.